Home Data Calendar Blog

ADPT

Tables

		2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30
Common Stock Value		0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.00	NA	0.00	NA	NA
Weighted Average Number Of Diluted Shares Outstanding		147.52	147.41	145.79	NA	144.70	144.40	143.51	NA	142.93	142.36	141.70	NA	140.83	140.36	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Weighted Average Number Of Shares Outstanding Basic		147.52	147.41	145.79	NA	144.70	144.40	143.51	NA	142.93	142.36	141.70	NA	140.83	140.36	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Earnings Per Share Basic		-0.22	-0.31	-0.33	-0.48	-0.35	-0.33	-0.40	-0.28	-0.32	-0.37	-0.44	-0.44	-0.40	-0.35	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Earnings Per Share Diluted		-0.22	-0.31	-0.33	-0.48	-0.35	-0.33	-0.40	-0.28	-0.32	-0.37	-0.44	-0.44	-0.40	-0.35	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA

		2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30
Revenue From Contract With Customer Excluding Assessed Tax		46.44	43.19	41.87	45.78	37.92	48.93	37.65	55.20	47.83	43.66	38.62	37.93	39.47	38.51	38.44	30.18	26.30	20.99	20.91	24.21	26.06	22.14	12.67	17.19	17.19	11.57
Revenues		46.44	43.19	41.87	45.78	37.92	48.93	37.65	55.20	47.83	43.66	38.62	37.93	39.47	38.51	38.44	30.18	26.30	20.99	20.91	24.21	26.06	22.14	12.67	17.19	17.19	11.57
Cost Of Goods And Services Sold		16.67	19.32	18.05	19.62	19.35	17.91	18.68	16.59	14.91	13.22	13.19	14.36	14.19	10.77	9.99	6.22	6.05	4.91	5.34	5.95	5.60	5.73	4.99	5.28	5.36	5.04
Costs And Expenses		79.07	90.51	90.64	116.85	88.88	96.74	94.84	94.38	93.26	96.16	101.69	99.53	95.79	88.27	79.72	74.42	63.35	57.90	55.53	48.40	44.11	38.24	32.71	31.34	26.35	24.88
Research And Development Expense		24.16	25.35	30.25	28.75	28.53	32.24	32.60	31.22	35.66	37.04	37.84	34.70	36.07	37.80	33.77	35.83	30.31	25.99	23.93	21.19	20.51	16.53	12.48	11.07	9.78	9.45
General And Administrative Expense		17.26	17.89	19.60	20.73	20.07	22.30	20.83	22.43	20.75	21.20	24.14	23.35	20.15	16.07	14.94	13.40	12.08	12.24	11.82	8.19	8.48	6.66	7.00	6.50	4.74	4.63
Selling And Marketing Expense		20.55	20.31	22.32	21.91	20.49	23.87	22.31	23.72	21.51	24.28	26.09	26.70	24.95	23.22	20.60	18.55	14.47	14.33	14.01	12.64	9.10	8.90	7.82	8.07	6.04	5.33
Operating Income Loss		-32.63	-47.32	-48.76	-71.07	-50.96	-47.82	-57.19	-39.19	-45.43	-52.50	-63.07	-61.60	-56.33	-49.77	-41.28	-44.24	-37.05	-36.91	-34.62	-24.19	-18.05	-16.11	-20.05	-14.14	-9.16	-13.31
Interest Expense		2.94	2.70	2.99	3.01	3.65	3.60	3.53	3.58	0.65	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Interest Paid Net		2.16	2.09	2.29	1.90	2.45	1.88	2.76	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Allocated Share Based Compensation Expense		13.52	12.96	14.30	15.56	15.34	17.34	14.67	14.29	14.14	14.18	12.86	11.88	11.64	11.20	8.50	7.30	6.50	6.40	4.70	3.40	3.30	3.30	3.00	3.00	2.60	2.40
Profit Loss		-32.10	-46.25	-47.53	-69.47	-50.33	-47.81	-57.70	-40.17	-45.32	-52.08	-62.80	-61.36	-56.00	-49.30	-40.64	-44.57	-36.72	-33.53	-31.40	-20.61	-13.95	-15.66	-18.39	-13.27	-8.29	NA
Net Income Loss		-32.07	-46.22	-47.51	-69.44	-50.30	-47.81	-57.70	-40.13	-45.28	-52.05	-62.74	-61.43	-55.90	-49.30	-40.64	-44.57	-36.72	-33.53	-31.40	-20.61	-13.95	-15.66	-18.39	-13.27	-8.29	-12.49
Comprehensive Income Net Of Tax		-31.39	-46.30	-47.83	-68.98	-49.66	-46.80	-55.49	-38.27	-45.45	-53.06	-66.38	-62.58	-56.11	-49.72	-40.90	-45.10	-37.45	-34.70	-28.76	-20.51	-13.76	-15.37	-18.19	-13.18	-8.25	-12.45

		2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30
Assets		558.51	584.87	620.32	661.13	717.68	764.54	791.46	856.62	884.21	806.63	858.19	923.34	992.61	1033.37	1072.09	1116.41	1095.47	854.82	874.89	912.30	917.39	601.39	NA	332.69	NA	NA
Liabilities		334.93	343.44	345.56	352.86	356.05	368.57	367.51	392.52	396.39	288.32	304.94	319.24	341.06	340.06	346.38	373.15	320.43	324.88	323.32	341.26	331.47	323.84	NA	29.94	NA	NA
Liabilities And Stockholders Equity		558.51	584.87	620.32	661.13	717.68	764.54	791.46	856.62	884.21	806.63	858.19	923.34	992.61	1033.37	1072.09	1116.41	1095.47	854.82	874.89	912.30	917.39	601.39	NA	332.69	NA	NA
Stockholders Equity		223.77	241.60	274.91	308.40	361.73	396.04	424.02	464.17	487.84	518.30	553.21	603.99	651.51	693.18	725.59	743.27	775.05	529.94	551.56	571.04	585.92	-284.37	-273.47	-258.11	-248.08	-242.44

		2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30
Assets Current		308.35	351.55	374.03	410.19	435.24	476.81	501.33	562.15	564.38	438.57	419.12	402.75	467.03	643.73	764.96	726.91	877.36	599.52	584.65	612.69	601.36	442.30	NA	180.72	NA	NA
Cash And Cash Equivalents At Carrying Value		38.08	59.82	71.23	65.06	88.71	109.24	94.61	90.03	217.55	76.41	114.81	139.06	122.40	184.19	173.62	123.44	497.08	365.44	212.69	96.58	74.94	48.46	NA	55.03	NA	NA
Accounts Receivable Net Current		40.81	35.61	42.02	37.97	31.21	31.55	30.97	40.06	26.55	23.71	22.52	17.41	17.12	14.17	19.75	10.05	11.86	7.91	9.38	12.68	9.26	7.25	NA	4.81	NA	NA
Inventory Net		11.96	13.21	13.29	14.45	19.49	18.96	19.87	14.45	17.34	18.78	21.00	19.26	18.23	18.61	17.42	14.06	10.74	10.54	10.52	9.07	8.67	8.00	NA	7.84	NA	NA
Prepaid Expense And Other Assets Current		12.25	10.85	9.85	11.37	13.40	9.07	9.79	9.44	12.41	12.35	12.04	13.02	16.63	12.53	13.52	14.54	19.68	10.69	9.57	14.08	10.00	4.04	NA	3.06	NA	NA

		2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30
Amortization Of Intangible Assets		0.43	0.42	0.42	0.43	0.43	0.42	0.42	0.43	0.43	0.42	0.42	0.43	0.43	0.42	0.42	0.43	0.43	0.42	0.42	0.43	0.43	0.42	0.42	0.43	0.43	0.42
Property Plant And Equipment Net		51.31	55.42	65.26	68.23	76.75	79.39	81.29	83.45	86.66	86.85	85.99	85.26	87.82	75.23	56.31	39.69	31.16	26.83	24.95	60.35	46.54	22.30	NA	19.12	NA	NA
Goodwill		118.97	118.97	118.97	118.97	118.97	118.97	118.97	118.97	118.97	118.97	118.97	118.97	118.97	118.97	118.97	118.97	118.97	118.97	118.97	118.97	118.97	118.97	NA	118.97	NA	NA
Finite Lived Intangible Assets Net		3.85	4.28	4.71	5.13	5.56	5.99	6.41	6.83	7.26	7.68	8.11	8.53	8.96	9.38	9.81	10.22	10.65	11.08	11.50	11.93	12.36	12.78	NA	13.63	NA	NA
Other Assets Noncurrent		2.65	3.15	3.39	3.59	2.98	3.35	2.18	2.06	2.20	0.78	0.87	0.88	0.87	0.72	0.72	0.60	1.00	1.27	1.00	0.78	0.72	NA	NA	0.19	NA	NA

		2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30
Liabilities Current		87.63	88.13	82.95	88.02	93.30	95.33	90.10	109.79	104.02	111.47	115.07	113.81	122.38	116.65	106.77	105.20	100.83	93.42	77.95	78.31	73.38	74.86	NA	22.80	NA	NA
Accounts Payable Current		7.35	9.87	12.17	7.72	4.48	9.16	6.33	8.08	4.16	2.72	5.96	3.31	8.25	6.09	5.20	3.24	5.41	3.69	3.90	4.45	2.42	2.94	NA	1.79	NA	NA
Accrued Liabilities Current		6.06	6.71	7.91	8.60	10.15	8.36	8.04	12.42	10.70	9.45	10.41	9.34	17.03	13.54	13.48	13.16	5.35	4.83	3.80	4.37	3.38	5.02	NA	2.56	NA	NA
Contract With Customer Liability Current		51.86	52.23	46.87	48.63	55.34	57.92	60.32	64.11	67.89	80.91	83.50	80.46	79.95	83.55	78.35	73.32	78.19	75.70	64.57	60.99	61.27	61.19	NA	12.70	NA	NA

		2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30
Long Term Debt Noncurrent		132.70	132.08	131.54	130.66	126.73	NA	NA	125.36	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Minority Interest		-0.20	-0.17	-0.15	-0.12	-0.10	-0.07	-0.07	-0.07	-0.03	0.01	0.05	0.11	0.03	0.13	0.13	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Other Liabilities Noncurrent		0.02	0.02	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	2.38	1.50	NA	0.09	NA	NA	NA	NA	NA	NA
Operating Lease Liability Noncurrent		81.80	84.37	86.90	89.39	91.82	94.18	96.49	98.77	100.52	102.73	104.98	106.69	108.04	103.77	95.25	104.33	42.37	42.50	36.55	NA	NA	NA	NA	NA	NA	NA

		2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30
Stockholders Equity		223.77	241.60	274.91	308.40	361.73	396.04	424.02	464.17	487.84	518.30	553.21	603.99	651.51	693.18	725.59	743.27	775.05	529.94	551.56	571.04	585.92	-284.37	-273.47	-258.11	-248.08	-242.44
Stockholders Equity Including Portion Attributable To Noncontrolling Interest		223.57	241.43	274.77	308.28	361.64	395.97	423.95	464.10	487.81	518.32	553.25	604.10	651.54	693.31	725.72	743.27	775.05	529.94	551.56	571.04	NA	NA	NA	-258.11	NA	NA
Common Stock Value		0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.00	NA	0.00	NA	NA
Additional Paid In Capital		1493.39	1479.83	1466.84	1452.50	1436.86	1421.51	1402.69	1387.35	1372.75	1357.76	1339.60	1324.01	1308.95	1294.51	1277.20	1253.97	1240.65	958.10	945.03	935.83	930.21	NA	NA	37.90	NA	NA
Retained Earnings Accumulated Deficit		-1270.13	-1238.06	-1191.84	-1144.33	-1074.89	-1024.59	-976.78	-919.08	-878.95	-833.67	-781.63	-718.89	-657.46	-601.55	-552.25	-511.61	-467.04	-430.32	-396.79	-365.48	-344.87	-330.92	NA	-295.91	NA	NA
Accumulated Other Comprehensive Income Loss Net Of Tax		0.50	-0.18	-0.11	0.21	-0.25	-0.89	-1.91	-4.12	-5.97	-5.80	-4.78	-1.14	0.01	0.22	0.63	0.89	1.43	2.15	3.31	0.67	0.57	0.38	NA	-0.11	NA	NA
Minority Interest		-0.20	-0.17	-0.15	-0.12	-0.10	-0.07	-0.07	-0.07	-0.03	0.01	0.05	0.11	0.03	0.13	0.13	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value		13.52	12.96	14.30	15.56	15.34	17.34	14.67	14.29	14.14	14.18	12.86	11.88	11.64	11.25	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA

		2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30
Net Cash Provided By Used In Operating Activities		-27.07	-17.30	-38.35	-26.93	-46.68	-23.56	-59.15	-30.02	-42.41	-47.06	-64.45	-53.83	-43.44	-37.21	-58.24	-39.84	-47.16	-31.08	-31.61	-26.79	-30.14	-15.97	278.30	-5.41	-11.69	NA
Net Cash Provided By Used In Investing Activities		5.29	5.88	44.51	3.21	26.14	37.32	62.98	-97.54	58.02	4.75	37.69	67.21	-21.27	41.45	93.82	-340.05	-97.25	177.49	142.76	46.68	-260.85	-45.35	-222.18	27.63	5.13	NA
Net Cash Provided By Used In Financing Activities		0.04	0.03	0.04	0.09	0.02	1.47	0.67	0.01	125.52	3.99	2.75	3.28	2.93	6.33	14.61	6.25	276.04	6.34	4.96	1.75	319.55	-1.50	0.12	0.28	0.06	NA

		2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30
Net Cash Provided By Used In Operating Activities		-27.07	-17.30	-38.35	-26.93	-46.68	-23.56	-59.15	-30.02	-42.41	-47.06	-64.45	-53.83	-43.44	-37.21	-58.24	-39.84	-47.16	-31.08	-31.61	-26.79	-30.14	-15.97	278.30	-5.41	-11.69	NA
Net Income Loss		-32.07	-46.22	-47.51	-69.44	-50.30	-47.81	-57.70	-40.13	-45.28	-52.05	-62.74	-61.43	-55.90	-49.30	-40.64	-44.57	-36.72	-33.53	-31.40	-20.61	-13.95	-15.66	-18.39	-13.27	-8.29	-12.49
Profit Loss		-32.10	-46.25	-47.53	-69.47	-50.33	-47.81	-57.70	-40.17	-45.32	-52.08	-62.80	-61.36	-56.00	-49.30	-40.64	-44.57	-36.72	-33.53	-31.40	-20.61	-13.95	-15.66	-18.39	-13.27	-8.29	NA
Increase Decrease In Other Operating Capital Net		-0.00	-0.02	0.00	-0.00	0.06	-0.00	0.01	-0.00	-0.07	NA	NA	0.00	0.15	0.00	0.12	0.06	0.00	0.00	0.21	0.06	0.54	NA	NA	-0.02	-0.00	NA
Increase Decrease In Accounts Receivable		5.20	-6.41	4.05	6.77	-0.33	0.62	-9.09	13.51	2.84	1.19	5.11	0.29	2.95	-5.58	9.71	-1.81	3.94	-1.47	-3.28	3.42	1.95	3.19	-0.74	-7.56	7.95	NA
Increase Decrease In Inventories		-1.70	0.82	-1.11	-3.98	0.27	-0.07	6.61	-3.03	-0.07	0.55	1.74	1.03	-0.38	1.19	3.36	3.33	0.20	0.02	1.45	0.40	0.66	0.15	0.02	0.73	-0.61	NA
Share Based Compensation		13.52	12.96	14.30	15.56	15.34	17.34	14.67	14.29	14.14	14.18	12.86	11.88	11.64	11.25	8.48	7.24	6.47	6.37	4.67	3.41	3.33	3.33	3.05	3.05	2.55	NA

		2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30
Net Cash Provided By Used In Investing Activities		5.29	5.88	44.51	3.21	26.14	37.32	62.98	-97.54	58.02	4.75	37.69	67.21	-21.27	41.45	93.82	-340.05	-97.25	177.49	142.76	46.68	-260.85	-45.35	-222.18	27.63	5.13	NA
Payments To Acquire Property Plant And Equipment		0.34	1.73	1.51	1.30	2.78	3.70	2.92	2.54	5.43	5.30	3.08	9.24	14.62	22.04	15.84	9.37	4.21	2.26	2.96	2.42	3.43	1.52	3.83	2.51	2.19	NA

		2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30
Net Cash Provided By Used In Financing Activities		0.04	0.03	0.04	0.09	0.02	1.47	0.67	0.01	125.52	3.99	2.75	3.28	2.93	6.33	14.61	6.25	276.04	6.34	4.96	1.75	319.55	-1.50	0.12	0.28	0.06	NA

		2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30
Revenues		46.44	43.19	41.87	45.78	37.92	48.93	37.65	55.20	47.83	43.66	38.62	37.93	39.47	38.51	38.44	30.18	26.30	20.99	20.91	24.21	26.06	22.14	12.67	17.19	17.19	11.57
Operating, Immune Medicine Business		8.96	7.91	9.25	NA	13.25	23.04	16.22	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Operating, Mrd Business		37.47	35.28	32.63	NA	24.67	25.88	21.43	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Immune Medicine Service Revenue		3.50	1.80	4.70	NA	8.00	17.50	9.10	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Collaboration Revenue, Immune Medicine Revenue		3.51	1.76	4.69	7.91	8.01	17.54	9.12	16.28	21.32	15.08	13.70	14.51	15.45	17.63	16.06	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Immune Medicine Service Revenue, Medicare Reimbursements		1.00	NA	NA	0.20	0.00	NA	NA	0.40	0.10	0.00	0.20	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Regulatory Milestone Revenue, M R D Revenue		5.00	3.00	4.50	NA	NA	NA	NA	2.00	0.00	1.00	3.00	0.00	1.50	1.50	7.00	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Service, Immune Medicine Revenue		5.45	6.15	4.56	7.11	5.24	5.51	7.10	10.81	6.56	7.30	7.11	6.86	8.17	5.41	4.05	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Service, M R D Revenue		32.47	32.28	28.13	30.76	24.67	25.88	21.43	26.11	19.95	20.28	14.80	16.56	14.35	13.97	11.34	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Immune Medicine Revenue		8.96	7.91	9.25	15.02	13.25	23.04	16.22	27.09	27.88	22.38	20.82	21.37	23.61	23.04	20.11	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
M R D Revenue		37.47	35.28	32.63	30.76	24.67	25.88	21.43	28.11	19.95	21.28	17.80	16.56	15.85	15.47	18.34	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Medicare Reimbursements		1.50	1.50	1.50	1.00	1.90	1.30	1.00	1.50	1.10	1.40	1.40	0.40	1.50	3.10	0.80	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Revenue From Contract With Customer Excluding Assessed Tax		46.44	43.19	41.87	45.78	37.92	48.93	37.65	55.20	47.83	43.66	38.62	37.93	39.47	38.51	38.44	30.18	26.30	20.99	20.91	24.21	26.06	22.14	12.67	17.19	17.19	11.57
Operating, Immune Medicine Business		8.96	7.91	9.25	NA	13.25	23.04	16.22	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Operating, Mrd Business		37.47	35.28	32.63	NA	24.67	25.88	21.43	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Immune Medicine Service Revenue		3.50	1.80	4.70	NA	8.00	17.50	9.10	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Collaboration Revenue, Immune Medicine Revenue		3.51	1.76	4.69	7.91	8.01	17.54	9.12	16.28	21.32	15.08	13.70	14.51	15.45	17.63	16.06	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Immune Medicine Service Revenue, Medicare Reimbursements		1.00	NA	NA	0.20	0.00	NA	NA	0.40	0.10	0.00	0.20	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Regulatory Milestone Revenue, M R D Revenue		5.00	3.00	4.50	NA	NA	NA	NA	2.00	0.00	1.00	3.00	0.00	1.50	1.50	7.00	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Service, Immune Medicine Revenue		5.45	6.15	4.56	7.11	5.24	5.51	7.10	10.81	6.56	7.30	7.11	6.86	8.17	5.41	4.05	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Service, M R D Revenue		32.47	32.28	28.13	30.76	24.67	25.88	21.43	26.11	19.95	20.28	14.80	16.56	14.35	13.97	11.34	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Immune Medicine Revenue		8.96	7.91	9.25	15.02	13.25	23.04	16.22	27.09	27.88	22.38	20.82	21.37	23.61	23.04	20.11	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
M R D Revenue		37.47	35.28	32.63	30.76	24.67	25.88	21.43	28.11	19.95	21.28	17.80	16.56	15.85	15.47	18.34	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Medicare Reimbursements		1.50	1.50	1.50	1.00	1.90	1.30	1.00	1.50	1.10	1.40	1.40	0.40	1.50	3.10	0.80	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA

Plots across concepts

Line plots across dimensions of each concept